The clinical value of enzyme-multiplied immunoassay technique monitoring the plasma concentrations of cyclosporine A after renal transplantation

Cook, 2009, Cyclosporine A for neuroprotection: establishing dosing guidelines for safe and effective use, Expert Opin Drug Saf, 8, 411, 10.1517/14740330903066742 Masuo, 2009, Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen, Cancer Lett, 285, 66, 10.1016/j.canlet.2009.05.001 Densem, 2004, A novel polymorphism of the gene encoding furin, a TGF-betal activator, and the influence on cardiac allograft vasculopathy formation, Transpl Immunol, 13, 185, 10.1016/j.trim.2004.04.005 Ekberg, 2007, Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR study, Am J Transplant, 7, 560, 10.1111/j.1600-6143.2006.01645.x Velickovic-Radovanovic, 2009, Significance of the therapy monitoring of immunosuppressive medicines in renal transplantation patients, Acta Medica Med, 48, 22 Carbajal, 2004, Cyclosporine and low-dose ketoconazole in renal transplant recipients: a single-center experience, Transplantation, 77, 1038, 10.1097/01.TP.0000122343.51904.C3 Sabaté, 2000, Evaluation of the AxSYM monoclonal cyclosporin assay and comparison with radioimmunoassay, Ther Drug Mortit, 22, 474, 10.1097/00007691-200008000-00018 Steimer, 1999, Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific, Clin Chem, 45, 371, 10.1093/clinchem/45.3.371 Huang, 2009, Comparison of EMIT and HPLC in monitoring cyclosporine A in patients after renal transplantation, Pharm Clin Res, 17, 104 Kahan, 2008, Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine, Transplant Proc, 40, S17, 10.1016/j.transproceed.2008.10.019 Fangmann, 2010, Impact of daclizumab, low-dose cyclosporine, mycophenolate mofetil and steroids on renal function after kidney transplantation, Nephrol Dial Transplant, 25, 283, 10.1093/ndt/gfp468 Lin, 2009, Clinical study of application of sirolimus with dose-reduced or discontinued cyclosporine A for prevention of acute rejection after kidney transplantation, Chin J Surg, 47, 1319 Guo, 2010, Analysis of monitoring blood concentration of cyclosporin A after renal transplantation, Guide China Med, 8, 54 Ware, 2010, Current progress in pharmacogenetics and individualized immunosuppressive drug dosing in organ transplantation, Curr Opin Mol Ther, 12, 270 Bartoli, 2010, Falsely elevated whole blood cyclosporine concentrations measured by an immunoassay with automated pretreatment, Ther Drug Monit, 32, 791, 10.1097/FTD.0b013e3181fa560b Wan, 2006, Factors influencing the serum concentration of cyclosporine A, Chin J Pharm, 15, 152